Marder's condition improves but still not out of the woods

By
March 29, 2011 18:30

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Thanks to intensive treatment by medication and supervision by doctors at the Rabin Medical Center-Beilinson Campus, 27-year-old Shirli Marder - whose liver began to fail from an extremely rare complication of taking a painkilling pill - regained consciousness, reacted to her name and was carrying out simple instructions.

The Petah Tikva hospital said on Tuesday evening that her improved condition, also thanks to her young age, was at least a temporary reversal of her acute condition. But doctors added that it was not yet known whether it would decline and require a liver transplant.

Dr. Boaz Tadmor, who is heading the team that is treating her, said she remains officially in "critical condition."

Related Content

Breaking news
August 18, 2018
U.N. chief suggests options for improved Palestinian protection

By REUTERS